Zeltia en el Pais

Zeltia gastará 123 millones para buscar remedio al cáncer de ovario

Leer entrada completa

Revistas de Biotecnologia

African Journal of Biotechnology
Applied Biochemistry and Biotechnology
Applied Microbiology and Biotechnology
Asian Biotechnology and Development Review
Australasian Biotechnology
Biotechnology Advances
Biotechnology and Applied Biochemistry
Biotechnology and Bioengineering
Biotechnology and Development Monitor
Biotechnology Law Report
Biotchnology Letters
Biotechnology Progress
Biotechnology Software and Internet Journal
Biotechnology Techniques
Biotechnology Progress
Biotecnologia Aplicada
Brazilian Archives of Biology and Technology
Chinese Journal of Agricultural Biotechnology
Chinese Journal of Biotechnology
Current Opinion in Biotechnology
Electronic Journal of Biotechnology
Global Journal of Biotechnology and Biochemistry
Indian Journal of Biotechnology
International Journal of Biotechnology
International Journal of Biotechnology and Biochemistry
Journal of Biomedicine and Biotechnology
Journal of Biopharmaceutics and Biotechnology
Journal of Biotechnology
Journal of Chemical Technology and Biotechnology
Journal of Commercial Biotechnology
Journal of Horticultural Science and Biotechnology
Journal of Industrial Microbiology and Biotechnology
Journal of Molecular Microbiology and Biotechnology
Journal of Tropical Microbiology and Biotechnology
Journal of Plant Biochemistry and Biotechnology
Journal of Plant Biotechnology
Marine Biotechnology
Microbial Biotechnology
Minerva Biotecnologica
Nature Biotechnology
Open Biotechnology Journal
Plant Biotechnology
Plant Biotechnology Journal
Reviews in Molecular Biotechnology
Trends in Biotechnology
World Journal of Microbiology and Biotechnology

Leer entrada completa

Hoy en la prensa

Neocodex alcanza la excelencia en Biomedicina

SICKO EUROPE

Leer entrada completa

Zeltia

Pharmamar será empresa farmacéutica cuando Yondelis inicie su venta

INTERVIEW Zeltia targets sale of Yondelis in at least UK, Germany this year

• Dice que: "PharmaMar would launch the product at the key European oncology conference to be held in Barcelona Sept 23-27" ("Pharmamar lanzará su producto en la Conferencia Europea de Oncología a celebrar en Barcelona entre el 23 y el 27 de septiembre")

Oncology Drug Development-Mid-Year 2007 Update

Alejandro Yovine es el nuevo director desarrollo clínico de Pharmamar

Acerca de Alejandro Yovine:

• Publicaciones científicas en Google Scholar y en Pubmed
• Perfil en ZoomInfo

Leer entrada completa